Company Filing History:
Years Active: 2023-2025
Title: Yinjia Gao: Innovator in Tumor Microenvironment Probes and Gene Therapy
Introduction
Yinjia Gao is a prominent inventor based in Suzhou, China. He has made significant contributions to the fields of tumor imaging and gene therapy. With a total of 3 patents, his work focuses on innovative solutions that enhance medical treatments and diagnostics.
Latest Patents
Yinjia Gao's latest patents include a groundbreaking invention titled "HO-responsive crosslinking near-infrared molecular probe for tumor microenvironment and use therefor." This invention discloses a novel molecular probe that utilizes HO in a tumor microenvironment for crosslinking at tumor sites. The preparation method involves several steps, including the amide condensation of 2-propynylamine and Fmoc-Lys(Boc)-OH, leading to a compound that significantly improves tumor imaging results.
Another notable patent is related to "lipid compound as well as lipid vector, nucleic acid lipid nanoparticle composition, and pharmaceutical preparation comprising the same." This disclosure pertains to a series of lipid compounds that exhibit pH responsiveness and high encapsulation efficiency for nucleic acid drugs. These compounds enhance the in-vivo delivery efficiency of nucleic acid drugs, showcasing a promising market application prospect.
Career Highlights
Yinjia Gao has worked with notable organizations, including Purecodon Biopharma Ltd. and Soochow University. His experience in these institutions has allowed him to develop innovative technologies that address critical challenges in medical science.
Collaborations
Yinjia Gao has collaborated with esteemed colleagues such as Ke Huang and Yingwen Li. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Yinjia Gao's contributions to the fields of tumor imaging and gene therapy highlight his innovative spirit and dedication to improving medical technologies. His patents reflect a commitment to advancing healthcare solutions that can significantly impact patient outcomes.